New trends for overcoming ABCG2/BCRP-mediated resistance to cancer therapies
Published 2015 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
New trends for overcoming ABCG2/BCRP-mediated resistance to cancer therapies
Authors
Keywords
ABCG2, resistance, Efflux, Chemotherapy, Cytotoxic, Targeted agent, PDT, Radiation
Journal
JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH
Volume 34, Issue 1, Pages -
Publisher
Springer Nature
Online
2015-12-30
DOI
10.1186/s13046-015-0275-x
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Enhanced efficacy of photodynamic therapy by inhibiting ABCG2 in colon cancers
- (2015) Ju Hee Kim et al. BMC CANCER
- FL118, a novel camptothecin derivative, is insensitive to ABCG2 expression and shows improved efficacy in comparison with irinotecan in colon and lung cancer models with ABCG2-induced resistance
- (2015) David Westover et al. Molecular Cancer
- Efficacy of PARP Inhibitor Rucaparib in Orthotopic Glioblastoma Xenografts Is Limited by Ineffective Drug Penetration into the Central Nervous System
- (2015) K. E. Parrish et al. MOLECULAR CANCER THERAPEUTICS
- Sorafenib and irinotecan (NEXIRI) as second- or later-line treatment for patients with metastatic colorectal cancer and KRAS-mutated tumours: a multicentre Phase I/II trial
- (2014) E Samalin et al. BRITISH JOURNAL OF CANCER
- FL118 Induces p53-Dependent Senescence in Colorectal Cancer Cells by Promoting Degradation of MdmX
- (2014) X. Ling et al. CANCER RESEARCH
- The multiple facets of drug resistance: one history, different approaches
- (2014) Evandro Niero et al. JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH
- Breast Cancer Resistance Protein (BCRP/ABCG2) and P-glycoprotein (P-GP/ABCB1) Restrict Oral Availability and Brain Accumulation of the PARP Inhibitor Rucaparib (AG-014699)
- (2014) Selvi Durmus et al. PHARMACEUTICAL RESEARCH
- Interaction of the Efflux Transporters ABCB1 and ABCG2 With Imatinib, Nilotinib, and Dasatinib
- (2013) L N Eadie et al. CLINICAL PHARMACOLOGY & THERAPEUTICS
- Fluorouracil, Leucovorin, and Irinotecan Plus Either Sunitinib or Placebo in Metastatic Colorectal Cancer: A Randomized, Phase III Trial
- (2013) Alfredo Carrato et al. JOURNAL OF CLINICAL ONCOLOGY
- Emerging role of cancer stem cells in the biology and treatment of ovarian cancer: basic knowledge and therapeutic possibilities for an innovative approach
- (2013) Federica Tomao et al. JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH
- Subpopulations of Stem-like Cells in Side Population Cells from the Human Bladder Transitional Cell Cancer Cell Line T24
- (2013) Z-F Ning et al. JOURNAL OF INTERNATIONAL MEDICAL RESEARCH
- Differential sensitivity in cell lines to photodynamic therapy in combination with ABCG2 inhibition
- (2013) Gemma A. Barron et al. JOURNAL OF PHOTOCHEMISTRY AND PHOTOBIOLOGY B-BIOLOGY
- Sorafenib Overcomes Irinotecan Resistance in Colorectal Cancer by Inhibiting the ABCG2 Drug-Efflux Pump
- (2013) T. Mazard et al. MOLECULAR CANCER THERAPEUTICS
- Antitumor Activity of FL118, a Survivin, Mcl-1, XIAP, and cIAP2 Selective Inhibitor, Is Highly Dependent on Its Primary Structure and Steric Configuration
- (2013) Jiuyang Zhao et al. MOLECULAR PHARMACEUTICS
- First-in-Humans Trial of an RNA Interference Therapeutic Targeting VEGF and KSP in Cancer Patients with Liver Involvement
- (2013) Josep Tabernero et al. Cancer Discovery
- Aldehyde dehydrogenase and ATP binding cassette transporter G2 (ABCG2) functional assays isolate different populations of prostate stem cells where ABCG2 function selects for cells with increased stem cell activity
- (2013) Kalyan J Gangavarapu et al. Stem Cell Research & Therapy
- Cancer stem cells
- (2012) Zuoren Yu et al. INTERNATIONAL JOURNAL OF BIOCHEMISTRY & CELL BIOLOGY
- Strongly amphiphilic photosensitizers are not substrates of the cancer stem cell marker ABCG2 and provides specific and efficient light-triggered drug delivery of an EGFR-targeted cytotoxic drug
- (2012) Pål Kristian Selbo et al. JOURNAL OF CONTROLLED RELEASE
- Effect of 5-FU and MTX on the Expression of Drug-resistance Related Cancer Stem Cell Markers in Non-small Cell Lung Cancer Cells
- (2012) Hee Yi et al. KOREAN JOURNAL OF PHYSIOLOGY & PHARMACOLOGY
- Pivotal roles of peptide transporter PEPT1 and ATP-binding cassette (ABC) transporter ABCG2 in 5-aminolevulinic acid (ALA)-based photocytotoxicity of gastric cancer cells in vitro
- (2012) Yuichiro Hagiya et al. Photodiagnosis and Photodynamic Therapy
- A Novel Small Molecule FL118 That Selectively Inhibits Survivin, Mcl-1, XIAP and cIAP2 in a p53-Independent Manner, Shows Superior Antitumor Activity
- (2012) Xiang Ling et al. PLoS One
- Sildenafil Reverses ABCB1- and ABCG2-Mediated Chemotherapeutic Drug Resistance
- (2011) Z. Shi et al. CANCER RESEARCH
- 14-Aminocamptothecins: Their Synthesis, Preclinical Activity, and Potential Use for Cancer Treatment
- (2011) Jian-Xin Duan et al. JOURNAL OF MEDICINAL CHEMISTRY
- Silencing or Stimulation? siRNA Delivery and the Immune System
- (2011) Kathryn A. Whitehead et al. Annual Review of Chemical and Biomolecular Engineering
- Prednisone plus cabazitaxel or mitoxantrone for metastatic castration-resistant prostate cancer progressing after docetaxel treatment: a randomised open-label trial
- (2010) Johann Sebastian de Bono et al. LANCET
- Substrate Affinity of Photosensitizers Derived from Chlorophyll-a: The ABCG2 Transporter Affects the Phototoxic Response of Side Population Stem Cell-like Cancer Cells to Photodynamic Therapy
- (2010) Janet Morgan et al. MOLECULAR PHARMACEUTICS
- Evidence of RNAi in humans from systemically administered siRNA via targeted nanoparticles
- (2010) Mark E. Davis et al. NATURE
- Cabazitaxel
- (2010) Matthew D. Galsky et al. NATURE REVIEWS DRUG DISCOVERY
- Interaction of nilotinib, dasatinib and bosutinib with ABCB1 and ABCG2: implications for altered anti-cancer effects and pharmacological properties
- (2009) C Hegedűs et al. BRITISH JOURNAL OF PHARMACOLOGY
- A water soluble prodrug of a novel camptothecin analog is efficacious against breast cancer resistance protein-expressing tumor xenografts
- (2009) Mika Endo et al. CANCER CHEMOTHERAPY AND PHARMACOLOGY
- Silencing the Breast Cancer Resistance Protein Expression and Function in Caco-2 Cells Using Lentiviral Vector-Based Short Hairpin RNA
- (2009) W. Zhang et al. DRUG METABOLISM AND DISPOSITION
- Influence of the dual ABCB1 and ABCG2 inhibitor tariquidar on the disposition of oral imatinib in mice
- (2009) Erin R Gardner et al. JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH
- Breast cancer resistant protein (BCRP) is a molecular determinant of the outcome of photodynamic therapy (PDT) for centrally located early lung cancer
- (2009) Jitsuo Usuda et al. LUNG CANCER
- The promises and pitfalls of RNA-interference-based therapeutics
- (2009) Daniela Castanotto et al. NATURE
- Sunitinib (Sutent, SU11248), a Small-Molecule Receptor Tyrosine Kinase Inhibitor, Blocks Function of the ATP-Binding Cassette (ABC) Transporters P-Glycoprotein (ABCB1) and ABCG2
- (2008) S. Shukla et al. DRUG METABOLISM AND DISPOSITION
- Immunohistochemical expression of BCRP and ERCC1 in biopsy specimen predicts survival in advanced non-small-cell lung cancer treated with cisplatin-based chemotherapy
- (2008) Shuji Ota et al. LUNG CANCER
- Expression of breast cancer resistance protein is associated with a poor clinical outcome in patients with small-cell lung cancer
- (2008) Young Hak Kim et al. LUNG CANCER
- Contribution of the drug transporter ABCG2 (breast cancer resistance protein) to resistance against anticancer nucleosides
- (2008) C. de Wolf et al. MOLECULAR CANCER THERAPEUTICS
- Effect of the ATP-binding cassette drug transporters ABCB1, ABCG2, and ABCC2 on erlotinib hydrochloride (Tarceva) disposition in in vitro and in vivo pharmacokinetic studies employing Bcrp1-/-/Mdr1a/1b-/- (triple-knockout) and wild-type mice
- (2008) S. Marchetti et al. MOLECULAR CANCER THERAPEUTICS
- Differential mechanisms of bicalutamide-induced apoptosis in prostate cell lines
- (2008) M St John Floyd et al. PROSTATE CANCER AND PROSTATIC DISEASES
- Fractionated Irradiation Can Induce Functionally Relevant Multidrug Resistance Gene and Protein Expression in Human Tumor Cell Lines
- (2008) Dirk Bottke et al. RADIATION RESEARCH
Find the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
SearchAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started